Shopping Cart
Remove All
Your shopping cart is currently empty
XIAP-CASP7 PPI-IN-1 is a reversible inhibitor of the XIAP:CASP7 interaction, effectively disrupting the connection between XIAP and CASP7. It selectively induces apoptosis in MCF-7 and caspase-3 low-expression (CASP3/DR) triple-negative breast cancer cells. The compound overcomes chemoresistance by down-regulating β-catenin and associated ABC transporters in paclitaxel-resistant MCF-7 cells. XIAP-CASP7 PPI-IN-1 is useful for breast cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | XIAP-CASP7 PPI-IN-1 is a reversible inhibitor of the XIAP:CASP7 interaction, effectively disrupting the connection between XIAP and CASP7. It selectively induces apoptosis in MCF-7 and caspase-3 low-expression (CASP3/DR) triple-negative breast cancer cells. The compound overcomes chemoresistance by down-regulating β-catenin and associated ABC transporters in paclitaxel-resistant MCF-7 cells. XIAP-CASP7 PPI-IN-1 is useful for breast cancer research. |
| In vitro | XIAP-CASP7 PPI-IN-1 (Compound 643943) exhibits the highest cytotoxicity against MCF-7 cells at concentrations of 0-50 μM over 4-24 hours, mediated by apoptotic signaling. It binds to CASP7 via Asp93 at 0-0.5 nM μM over 24 hours, releasing active CASP7 from XIAP and inducing cell death. Additionally, at 1.25-5 μM over 24 hours, it acts synergistically with anticancer drugs, sensitizing Paclitaxel-resistant MCF-7 cells (7TR) to chemotherapy. |
| In vivo | The compound XIAP-CASP7 PPI-IN-1 (Compound 643943), administered at a dosage of 20 mg/kg intraperitoneally once daily for 2 weeks, exhibits antitumor activity in a mouse model of breast cancer. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.